Loscertales, Javier
https://orcid.org/0000-0003-3561-3758
Mayo Clinic
Hospital Universitario de La Princesa
Citations 2
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
Fraser, Graeme , Chanan‐Khan, Asher , Silva, Rodrigo Santucci, Janssens, Ann , Mayer, Jiřı́ , Bartlett, Nancy L. , Dilhuydy, Marie‐Sarah, Loscertales, Javier , Avigdor, Abraham , Rule, Simon , Samoilova, Olga , Pavlovsky, Miguel Arturo , Mato, Anthony R. , Hallek, Michael , Salman, Mariya, Tamegnon, Monelle, Sun, Steven , Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram , Howes, Angela, Cramer, Paula , Bartlett, Nancy L , Rule, Simon , Demırkan, Fatih , Grosicki, Sebastian , Dilhuydy, Marie‐Sarah, Goy, Andre Henri
Leukemia & Lymphoma | August 7, 2020 | Volume: 61 | Issue: 13 | Pages: 3188-3197
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HE
Cramer, Paula , Fraser, Graeme , Santucci-Silva, Rodrigo, Grosicki, Sebastian , Dilhuydy, Marie‐Sarah, Janssens, Ann , Loscertales, Javier , Rule, Simon , Traina, Shana, Chan, Eric K. H., Diels, Joris , Sengupta, Nishan , Mahler, Michelle, Salman, Mariya, Howes, Angela, Chanan‐Khan, Asher , Chanan-Khan, Asher, Dilhuydy, Marie‐Sarah, Goy, Andre Henri
Leukemia & Lymphoma | January 3, 2018 | Volume: 59 | Issue: 9 | Pages: 2075-2084